下肢淋巴水肿患者慢性静脉功能不全的患病率与临床特征:系统综述与荟萃分析
GRADE证据确定性极低),异质性显著(I2=95.6%)。在5项病例定义更清晰、静脉评估系统且分母明确的研究中,合并患病率为48.8%(95%CI 23.1-75.1%;证据确定性极低),异质性持续存在(I2=92.2%)。结论认为CVI约见于半数下肢淋巴水肿患者,建议常规评估静脉疾病。
要点
- 下肢淋巴水肿患者中CVI合并患病率约45.7%,但证据确定性极低且异质性大。
- 在病例定义更清晰的研究中合并患病率为48.8%,异质性仍显著。
- 建议对下肢淋巴水肿患者常规评估静脉疾病,未来需标准化诊断与报告框架。
核心结论
- 在不同临床环境中,约半数下肢淋巴水肿患者存在慢性静脉功能不全(CVI)。
- 显著异质性反映诊断标准、研究人群和报告实践的差异。
- 应考虑对下肢淋巴水肿患者常规评估静脉疾病,未来研究需标准化诊断与报告框架。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Web of Science和Cochrane Library自建库至2025年11月13日。
- 纳入报告下肢淋巴水肿患者中CVI的观察性研究,两名评审独立进行文献筛选、数据提取和偏倚风险评估。
- 采用随机效应广义线性混合模型估计合并患病率。
主要发现
- 合并患病率为45.7%(95%CI 31.0-61.2%;GRADE证据确定性极低),异质性显著(I2=95.6%)。
- 在5项病例定义更清晰、静脉评估系统且分母明确的研究中,合并患病率为48.8%(95%CI 23.1-75.1%;证据确定性极低),异质性持续存在(I2=92.2%)。
- 年龄和体重指数变异较大,诊断标准和临床特征报告不一致,生活质量结局评估不频繁且不一致。
- 多数研究显示中至高度偏倚风险。
临床怎么用
- 对下肢淋巴水肿患者应考虑常规评估静脉疾病,以识别合并CVI。
- 临床评估需注意诊断标准不一致可能影响CVI识别,建议采用系统静脉评估。
局限性
- 证据确定性极低(GRADE),异质性显著(I2=95.6%),限制患病率估计的稳健性。
- 诊断标准和临床特征报告不一致,生活质量结局评估不频繁且不一致。
- 多数研究存在中至高度偏倚风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Lower extremity lymphoedema is increasingly being recognised as a multifactorial condition in which chronic venous insufficiency (CVI) may play an important role. This study aimed to estimate the pooled prevalence of CVI among individuals with lower extremity lymphoedema and to summarise clinical characteristics of patients with combined disease. DATA SOURCES: PubMed, Web of Science, and the Cochrane Library were searched from database inception through 13 November 2025. REVIEW METHODS: Observational studies reporting CVI among individuals with lower extremity lymphoedema were included. Study selection, data extraction, and risk of bias assessments were performed independently by two reviewers. Pooled prevalence was estimated using a random effects generalised linear mixed model. RESULTS: Eighteen studies were included; 12 contributed to the prevalence meta-analysis, comprising 1 563 individuals with lower extremity lymphoedema, of whom 570 had coexisting CVI. The pooled prevalence was 45.7% (95% confidence interval [CI] 31.0 - 61.2%; GRADE, very low certainty evidence), with substantial heterogeneity (I2 = 95.6%). In a restricted analysis limited to five studies with clearer case definitions, systematic venous assessment, and well defined denominators, pooled prevalence was 48.8% (95% CI 23.1 - 75.1%; very low certainty evidence), with persistent heterogeneity (I2 = 92.2%). Ten studies reported descriptive data, including 1 111 individuals with combined disease. The pooled female proportion was 66.3%. Age and body mass index varied widely. Diagnostic criteria and clinical characteristics were inconsistently reported. Quality of life outcomes were assessed infrequently and inconsistently. Most studies demonstrated moderate to high risk of bias. CONCLUSION: CVI was present in approximately half of patients with lower extremity lymphoedema across diverse clinical settings. Marked heterogeneity reflects differences in diagnostic criteria, study populations, and reporting practices. Routine evaluation of venous disease in patients with lower extremity lymphoedema should be considered. Standardised diagnostic and reporting frameworks are needed in future research.
引用
- Önefäldt D, Ali SH, Mani K, et al. Prevalence and Clinical Characteristics of Chronic Venous Insufficiency among Individuals with Lower Extremity Lymphoedema: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2026. PMID: 42431576. doi:10.1016/j.ejvs.2026.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。